Asthmanefrin Racepinephrine Inhalation Solution Bronchodilator, Starter Kit (Racepinephrine 11.25 mg) 10 individual foil wrapped…
Reason Discoloration
Yes — there is an active recall. 82 ongoing FDA recalls mention Pine (685 total). Check the affected lots below.
Recalls are matched by product description. A recall usually affects specific lots, not every package of Pine. “Active” means an FDA recall is still ongoing; “closed” means it was terminated or completed.
Reason Discoloration
Reason Subpotent drug.
Reason Subpotent Drug: Subpotent atorvastatin.
Reason Subpotent Drug: Subpotent atorvastatin.
Reason Subpotent Drug: Subpotent atorvastatin.
Reason Subpotent Drug: Subpotent atorvastatin.
Reason Subpotent Drug: Subpotent atorvastatin.
Reason Subpotent Drug: Subpotent atorvastatin.
Reason Subpotent Drug: Subpotent atorvastatin.
Reason Failed Dissolution Specifications
Reason Lack of Assurance of Sterility; all sterile human compounded drugs within expiry
Reason Lack of Assurance of Sterility; all sterile human compounded drugs within expiry
Reason Stability Data Does Not Support Expiry: potential loss of potency in drugs packaged and stored in syringes.
Reason Stability Data Does Not Support Expiry: potential loss of potency in drugs packaged and stored in syringes.
Reason Chemical Contamination; benzophenone leached from the product label varnish
Reason Chemical Contamination; benzophenone leached from the product label varnish
Reason Chemical Contamination; benzophenone leached from the product label varnish
Reason Labeling: Label Error on Declared Strength: Label incorrectly identifies product dose as 5ml instead of 10 ml.
Reason Lack of Assurance of Sterility: Process deficiencies were observed in the sterile ophthalmic and injectable products that could have compromised the…
Reason Lack of Assurance of Sterility: Process deficiencies were observed in the sterile ophthalmic and injectable products that could have compromised the…
Reason Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility
Reason CGMP Deviations: Firm did not adequately investigate customer complaints.
Reason CGMP Deviations: Firm did not adequately investigate customer complaints.
Reason CGMP Deviations: Firm did not adequately investigate customer complaints.
Reason Subpotent drug
Tell us which medications you take. If the FDA recalls one, we email you - in plain English, with what to do. Free.